"Ezetimibe Utilization Early After Acute Myocardial Infarction, EzAMI Trial"

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Myocardial InfarctionDyslipidemias
Interventions
DRUG

Ezetimibe 10mg

comparing upfront use of Ezetimibe (added to high intensity statins) after acute myocardial infarction versus selective Ezetimibe initiation to those failing to achieve LDL-C targets when assessed in follow up visit.

Trial Locations (1)

81511

RECRUITING

Aswan Heart Centre, Aswān

All Listed Sponsors
collaborator

Aswan Heart Centre

OTHER

lead

Cairo University

OTHER